TELA Bio (TELA) Gross Profit Growth (1y) (2019 - 2026)
TELA Bio (TELA) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 8.95% |
| 10 | TELA Bio | 36.24 Mn | 5.82 Mn | 13.94 Mn | -1.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.15% |
| Mar 31, 2026 | 0.06% |
| Dec 31, 2025 | 22.58% |
| Sep 30, 2025 | 8.64% |
| Jun 30, 2025 | 27.38% |
| Mar 31, 2025 | 10.37% |
| Dec 31, 2024 | -3.47% |
| Sep 30, 2024 | 23.77% |
| Jun 30, 2024 | 8.55% |
| Mar 31, 2024 | 43.53% |
| Dec 31, 2023 | 42.17% |
| Sep 30, 2023 | 41.95% |
| Jun 30, 2023 | 55.74% |
| Mar 31, 2023 | 57.99% |
| Dec 31, 2022 | 44.48% |
| Sep 30, 2022 | 59.04% |
| Jun 30, 2022 | 28.76% |
| Mar 31, 2022 | 44.27% |
| Dec 31, 2021 | 54.53% |
| Sep 30, 2021 | 40.01% |